Description
An antimalarial agent with anticancer activity; an iron(II) oxide-reactive endoperoxide that generates ROS; reduces the growth of various P. falciparum strains in vitro (IC50s = 3.98-20.36 nM); reduces parasitemia in mice infected with P. falciparum (CD50 = 140 mg/kg); reduces P. berghei infection in mice (ED50 = 5.6 mg/kg per day); inhibits growth of SK-N-AS, BE(2)-C, SK-N-DZ, and SHEP1 neuroblastoma cells from 100-400 μM; suppresses BE(2)-C cell colony formation in a soft agar assay and reduces tumor growth in a BE(2)-C mouse xenograft model
Formal name: (3R,5aS,6R,8aS,9R,12S,12aR)-octahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one
Synonyms: NSC 369397
Molecular weight: 282.3
CAS: 63968-64-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antiparasitics|Antiprotozoals||Product Type|Biochemicals|Natural Products||Research Area|Cancer|Cell Cycle|G1||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Parasitic Diseases|Malaria